Product Information
NAPROXEN 375 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0561 per EA under NDC 76282034101. Its NADAC has been published 515 times since Oct 12, 2016.
FDA first approved this application on Aug 24, 2011.
Strength
375 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282034101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA091305FDA Approved
8/24/2011
On Market Since
6/10/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 375 MG TABLET has been published 515 times since Oct 12, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0561 per EA |
|---|---|
| All-time high | $0.0808 (Jun 16, 2021) |
| All-time low | $0.0474 (Apr 17, 2024) |
| 52-week high | $0.0607 |
| 52-week low | $0.0561 |
| Median price | $0.0653 |
| Average price | $0.0662 |
| Largest weekly change | -28.8% (Apr 17, 2024) |
| Weeks tracked | 515 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0561 per EA (NDC 76282034101), effective Aug 19, 2026.
How has the price of NAPROXEN 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has held within roughly two percent of its current level. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?
Since Oct 12, 2016, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0474 (Apr 17, 2024) to a high of $0.0808 (Jun 16, 2021), with a median of $0.0653 per EA.
Are there cheaper alternatives to NAPROXEN 375 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NAPROXEN 375 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN 375 MG TABLET?
NAPROXEN 375 MG TABLET (NDC 76282034101) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.